Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle.

M. Hoedemaker, B. Korff, B. Edler, M. Emmert, E. Bleckmann
{"title":"Dynamics of Staphylococcus aureus infections during vaccination with an autogenous bacterin in dairy cattle.","authors":"M. Hoedemaker, B. Korff, B. Edler, M. Emmert, E. Bleckmann","doi":"10.1046/J.1439-0450.2001.00465.X","DOIUrl":null,"url":null,"abstract":"The effect of an autogenous vaccine against Staphylococcus aureus on S. aureus prevalence and mastitis, as well as on somatic cell count (SCC), was studied in a dairy herd with a high prevalence of S. aureus. The vaccination group (n = 35; 22 cows and 13 heifers) and the control group (n = 36; 23 cows and 13 heifers) received the vaccine or a placebo, respectively, according to the following protocol: all animals: basic immunization (twice, 3 weeks apart); cows: booster dose at the time of drying off, 5 and 2 weeks before calculated calving date; heifers: booster dose 2 and 5 weeks before calculated calving date. The vaccine or the placebo was administered subcutaneously in the area of the supramammary lymph nodes. Quarter milk samples were collected monthly and subjected to SCC and bacteriological evaluation. At this time, the animals were also checked for signs of clinical mastitis. Non-clinical S. aureus mastitis diagnoses were based on udder quarter SCC and a positive S. aureus culture. In order to compare the SCC in individual whole milk samples, records from the monthly milk quality testing were evaluated. Cow and udder quarter prevalence of S. aureus intramammary infections calculated for the experimental animals and quarters, respectively, did not differ between groups. However, during the lactation period following the boostcr dose, the prevalence of S. aureus increased in both groups (P < 0.05). The cumulative incidence of various mastitis diagnoses (clinical, subclinical, latent infection) due to S. aureus on an animal basis did not differ between groups. On an udder quarter basis, the cumulative incidence of subclinical mastitis was higher in vaccinated animals than in control animals (33.8 versus 26.0%; P < 0.05). This was mainly due to a higher cumulative incidence of subclinical mastitis in vaccinated than control heifers. The SCC in composite milk samples did not differ between groups, but increased as lactation progressed. The herd prevalence of S. aureus differed considerably throughout the study period, but declined consistently to below 10% at the end of the study period. Recent herd checks revealed a prevalence of S aureus infections of < 5%. It is concluded that the autogenous bacterin tested in this study did not have the desired effect on the prevalence of S. aureus infections and mastitis or SCC. The decline in S. aureus prevalence was very probably due to other factors than specific immunization against S. aureus.","PeriodicalId":17659,"journal":{"name":"Journal of veterinary medicine. B, Infectious diseases and veterinary public health","volume":"15 1","pages":"373-83"},"PeriodicalIF":0.0000,"publicationDate":"2001-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"32","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of veterinary medicine. B, Infectious diseases and veterinary public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1046/J.1439-0450.2001.00465.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 32

Abstract

The effect of an autogenous vaccine against Staphylococcus aureus on S. aureus prevalence and mastitis, as well as on somatic cell count (SCC), was studied in a dairy herd with a high prevalence of S. aureus. The vaccination group (n = 35; 22 cows and 13 heifers) and the control group (n = 36; 23 cows and 13 heifers) received the vaccine or a placebo, respectively, according to the following protocol: all animals: basic immunization (twice, 3 weeks apart); cows: booster dose at the time of drying off, 5 and 2 weeks before calculated calving date; heifers: booster dose 2 and 5 weeks before calculated calving date. The vaccine or the placebo was administered subcutaneously in the area of the supramammary lymph nodes. Quarter milk samples were collected monthly and subjected to SCC and bacteriological evaluation. At this time, the animals were also checked for signs of clinical mastitis. Non-clinical S. aureus mastitis diagnoses were based on udder quarter SCC and a positive S. aureus culture. In order to compare the SCC in individual whole milk samples, records from the monthly milk quality testing were evaluated. Cow and udder quarter prevalence of S. aureus intramammary infections calculated for the experimental animals and quarters, respectively, did not differ between groups. However, during the lactation period following the boostcr dose, the prevalence of S. aureus increased in both groups (P < 0.05). The cumulative incidence of various mastitis diagnoses (clinical, subclinical, latent infection) due to S. aureus on an animal basis did not differ between groups. On an udder quarter basis, the cumulative incidence of subclinical mastitis was higher in vaccinated animals than in control animals (33.8 versus 26.0%; P < 0.05). This was mainly due to a higher cumulative incidence of subclinical mastitis in vaccinated than control heifers. The SCC in composite milk samples did not differ between groups, but increased as lactation progressed. The herd prevalence of S. aureus differed considerably throughout the study period, but declined consistently to below 10% at the end of the study period. Recent herd checks revealed a prevalence of S aureus infections of < 5%. It is concluded that the autogenous bacterin tested in this study did not have the desired effect on the prevalence of S. aureus infections and mastitis or SCC. The decline in S. aureus prevalence was very probably due to other factors than specific immunization against S. aureus.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
奶牛接种自体细菌期间金黄色葡萄球菌感染的动态。
在金黄色葡萄球菌高发的奶牛群中,研究了自体金黄色葡萄球菌疫苗对金黄色葡萄球菌流行率和乳腺炎以及体细胞计数(SCC)的影响。接种组(n = 35;22头奶牛和13头小母牛)和对照组(n = 36;根据以下方案,分别对23头奶牛和13头小母牛接种疫苗或安慰剂:所有动物:基本免疫(两次,间隔3周);奶牛:在干燥时、计算产犊日期前5周和2周给予加强剂;小母牛:在计算产犊日期前2周和5周注射加强剂。疫苗或安慰剂在乳腺上淋巴结皮下注射。每月收集四分之一的牛奶样本,并进行SCC和细菌学评估。在这个时候,也检查了动物的临床乳腺炎的迹象。非临床金黄色葡萄球菌乳腺炎的诊断是基于乳房四分之一的鳞状细胞癌和金黄色葡萄球菌培养阳性。为了比较单个全脂牛奶样品中的SCC,对每月牛奶质量检测的记录进行了评估。分别计算实验动物和季度的奶牛和乳腺内金黄色葡萄球菌感染的患病率,各组之间没有差异。然而,在增强剂后的哺乳期,两组的金黄色葡萄球菌患病率均升高(P < 0.05)。在动物实验中,金黄色葡萄球菌引起的各种乳腺炎诊断(临床、亚临床、潜伏感染)的累积发病率在两组之间没有差异。在乳房四分之一的基础上,接种疫苗的动物的亚临床乳腺炎的累积发病率高于对照组(33.8%对26.0%;P < 0.05)。这主要是由于接种疫苗的小母牛亚临床乳腺炎的累积发病率高于对照。复合乳样品的SCC在组间无差异,但随着泌乳的进行而增加。在整个研究期间,金黄色葡萄球菌的群体流行率差异很大,但在研究期结束时一直下降到10%以下。最近的畜群检查显示金黄色葡萄球菌感染率< 5%。结论是,本研究中检测的自体细菌对金黄色葡萄球菌感染和乳腺炎或SCC的患病率没有预期的影响。金黄色葡萄球菌患病率的下降很可能是由于其他因素,而不是针对金黄色葡萄球菌的特异性免疫。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Keratoconjunctivitis and periorbital papillomatosis associated with heavy periorbital infestation by the tail louse Haematopinus quadripertusus in heifers. Comparative study of PCR as a direct assay and ELISA and AGID as indirect assays for the detection of bovine leukaemia virus. Histopathological and immunohistochemical study of lambs experimentally infected with Fasciola hepatica and Schistosoma bovis. Use of polymerase chain reaction to identify Brucella abortus strain RB51 among Brucella field isolates from cattle in Italy. Use of monoclonal antibodies in blocking ELISA detection of transmissible gastroenteritis virus in faeces of piglets.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1